Clinical Trials Sponsored by ODC Therapy

Total 1111 results

Baylor Research Institute
Mary Crowley Medical Research Center; ODC Therapy

Completed

Vaccination of Patients With Stage IV Melanoma With Dendritic Cells

Melanoma | Neoplasm Metastasis

United States
Everads Therapy

Recruiting

Everads Injector in Suprachoroidal Administration of TA Suspension, for Treatment of Patients With DME

Diabetic Macular Edema

Israel
Hand Therapy Barcelona

Recruiting

Hand Therapy Approach on Lumbrical Muscle Tears in Sport Climbers

Splints | Hand Injuries | Muscle Tear

Spain
3D Therapy, LLC

Completed

The Feasibility of VR for OUD

Opioid Use Disorder

United States
TCA Cellular Therapy

Suspended

Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury

Spinal Cord Injury

United States
TCA Cellular Therapy

Suspended

Phase II Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia(CI)

Coronary Artery Disease | Coronary Disease | Heart Disease | Coronary Atherosclerosis | Coronary Ischemia | Blocked Arteries

United States
TCA Cellular Therapy

Suspended

Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

United States
Azimuth Therapy Ltd.

Unknown

Evaluating the Adequacy of Giro-Couch to Support Prone Breast Boost Irradiation Using IMRT Technique With IGRT. (IN902)

Breast Cancer

Israel
TCA Cellular Therapy

Completed

Combination Stem Cell (MESENDO) Therapy for Utilization and Rescue of Infarcted Myocardium

Coronary Artery Disease | Coronary Disease | Coronary Arteriosclerosis | Coronary Atherosclerosis

United States
Lagniappe Physical Therapy

Unknown

Using a Smartphone App to Aid in Functional Mobility Return Following Total Knee Arthroplasty

Total Knee Arthroplasty

United States
TCA Cellular Therapy

Completed

Phase II Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia (MESENDO)

Peripheral Vascular Disease | Peripheral Artery Disease | Critical Limb Ischemia | Severe Leg Ischemia

United States
Cardiovascular Therapy LLC

Unknown

Magneto-rheology to Lower Blood Pressure

Hypertension

United States
Metabolic Therapy Inc.

Unknown

Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients

Alzheimer Disease
Metabolic Therapy Inc.

Unknown

Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease

Alzheimer Disease
Otic Therapy, LLC

Completed

Study to Assess the Safety and Efficacy of Benzocaine for Pain Relief in Children Presenting With Acute Otitis Media

Pain | Acute Otitis Media

United States
TCA Cellular Therapy

Completed

Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia (mesendo)

Peripheral Vascular Disease | Critical Limb Ischemia

United States
TCA Cellular Therapy

Completed

Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia (CI)

Coronary Artery Disease | Coronary Disease | Coronary Arteriosclerosis | Coronary Atherosclerosis | Coronary Ischemia

United States
JDC Tech

Completed

Clinical Study to Evaluate of The Whitening Efficacy and Safety of REMEWHITE (REMEWHITE)

Tooth Whitening

Korea, Republic of
Juventas Cell Therapy Ltd.

Not yet recruiting

A Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL) (B-ALL)

B-cell Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd.

Recruiting

A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)

B-cell Acute Lymphoblastic Leukemia

China
Targeted Therapy Technologies, LLC

Active, not recruiting

Topotecan Episcleral Plaque for Treatment of Retinoblastoma

Retinoblastoma

United States
Behavior Therapy Associates, LLP

Completed

A Web Application to Reduce Heavy Drinking in First-time DWI Offenders

Heavy Drinking | Driving Under the Influence | Alcohol Abstinence | Driving While Intoxicated

United States
Integrated Therapy Practice PC

Unknown

Study Evaluating the Benefit of Dry Needling for Patients With Neck Pain

Neck Pain

United States
Juventas Cell Therapy Ltd.

Recruiting

Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases

Lupus Erythematosus, Systemic

China
Juventas Cell Therapy Ltd.

Not yet recruiting

Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Non-hodgkin Lymphoma
Enspire DBS Therapy, Inc.

Recruiting

Pilot/Pivotal Study of DBS+Rehab After Stroke (RESTORE)

Stroke | Upper Extremity Paresis

United States
Juventas Cell Therapy Ltd.

Recruiting

Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

China
Targeted Therapy Technologies, LLC

Recruiting

Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

Macula Edema | Epiretinal Membrane | Branch Retinal Vein Occlusion | Radiation Retinopathy | Central Serous Retinopathy With Pit of Optic Disc | Commotio Retinae | Vitritis

United States
Enspire DBS Therapy, Inc.

Completed

Electrical Stimulation of the Dentate Nucleus for Upper Extremity Hemiparesis Due to Ischemic Stroke (EDEN)

Stroke

United States
SYZ Cell Therapy Co..

Completed

MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.

Solid Tumors

China
Juventas Cell Therapy Ltd.

Completed

A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Diffuse Non-Hodgkin Lymphoma

Diffuse Non-Hodgkin Lymphoma

China
Juventas Cell Therapy Ltd.

Completed

A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia

Relapsed or Refractory Acute Lymphoblastic Leukemia

China
Targeted Therapy Technologies, LLC

Unknown

A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema

Refractory Diabetic Macular Edema

United States
Immune-Onc Therapeutics

Recruiting

Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors

Advanced Solid Tumor

China
ADC Therapeutics S.A.

Recruiting

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

B-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin Lymphoma

United States, Spain, Italy, United Kingdom, Belgium, Czechia
ADC Therapeutics S.A.

Completed

A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9)

Diffuse Large B-cell Lymphoma

Spain, United States, Italy, Puerto Rico
ADC Therapeutics S.A.

Withdrawn

Long-term Registry of Patients Treated With Loncastuximab Tesirine

B-Cell Lymphomas

United States
ADC Therapeutics S.A.

Withdrawn

A Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Antitumor Activity of Loncastuximab Tesirine in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated Diffuse Large B-cell Lymphoma (LOTIS-8) (LOTIS-8)

Diffuse Large B-Cell Lymphoma

United States
ADC Therapeutics S.A.

Terminated

Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma

Follicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma

Spain, United States
ADC Therapeutics S.A.

Terminated

Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression

Breast Cancer | Non Small Cell Lung Cancer | Bladder Cancer | GastroEsophageal Cancer

United States, Belgium
ADC Therapeutics S.A.

Terminated

Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia

United States
Montefarmaco OTC SpA

Completed

Efficacy of a Red Yeast Rice Based Nutraceutical Plus Probiotic in Patients With Moderate Hypercholesterolemia

Hypercholesterolemia

Italy
Center of target therapy

Recruiting

Incidence of Viral Hepatitis D Relapses Upon Discontinuation of Bulevirtide in Patients With Chronic Hepatitis D and Negative HDV RNA

Chronic Hepatitis D

Russian Federation
Juventas Cell Therapy Ltd.

Recruiting

Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia

Relapsed or Refractory Acute Lymphoblastic Leukemia

China
SYZ Cell Therapy Co..

Recruiting

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Radiation Therapy Oncology Group

Completed

Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma

Glioma | Astrocytoma | Glioblastoma Multiforme
Targeted Therapy Technologies, LLC

Unknown

Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

Macular Edema | Epiretinal Membrane | Branch Retinal Vein Occlusion | Radiation Retinopathy | Central Serous Retinopathy With Pit of Optic Disc | Commotio Retinae | Vitritis

United States
Walsh University
Proaxis Therapy

Withdrawn

Influence of Patient-Informed Choice in a Novel Treatment Model for LBP

Mechanical Low Back Pain

United States
Montefarmaco OTC SpA

Recruiting

A Post-market Study to Evaluate the Effects of Sodium Hyaluronate Based Eye Drops in Patients Affected by Dry Eye Disease (M-DED-2020)

Opthalomology/Dry Eye

Italy
ADC Therapeutics S.A.

Recruiting

A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)

Diffuse Large B-Cell Lymphoma | High-grade B-cell Lymphoma

Taiwan, Korea, Republic of, United States, Brazil

3

Subscribe